Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Neurology 1999;53:1862
© 1999 American Academy of Neurology
Brief Communications
Amantadine-induced peripheral neuropathy
Lisa M. Shulman, MD,
Alireza Minagar, MD,
Khema Sharma, MD and
William J. Weiner, MD
From the Department of Neurology, University of Miami School of Medicine, Miami, FL.
Address correspondence and reprint requests to Dr. Lisa M. Shulman, Department of Neurology, University of Miami School of Medicine, 1501 N.W. 9 Avenue, Miami, FL 33136.
We report a 48-year-old woman with a 17-year history of PD who developed a peripheral sensory-motor neuropathy secondary to chronic administration (8 years) of amantadine. Discontinuation of amantadine resulted in resolution of trophic skin ulcers, paresthesias, and distal weakness. Amantadine may be hazardous to patients with severe and chronic livedo reticularis.
Key words: AmantadinePeripheral neuropathyPD.
This article has been cited by other articles:

|
 |

|
 |
 
M. Nolano, V. Provitera, A. Estraneo, M. M. Selim, G. Caporaso, A. Stancanelli, A. M. Saltalamacchia, B. Lanzillo, and L. Santoro
Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation
Brain,
July 1, 2008;
131(7):
1903 - 1911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maschke, C. M. Gomez, P. J. Tuite, and J. Konczak
Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia
Brain,
October 1, 2003;
126(10):
2312 - 2322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Swerdloff, S. C. Tarras, L. M. Shulman, A. Minagar, K. Sharma, and W. J. Weiner
Amantadine-induced peripheral neuropathy
Neurology,
August 8, 2000;
55(3):
456 - 457.
[Full Text]
[PDF]
|
 |
|
|